You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Market News

Market News

HomeMarket NewsInformation about Individual Stocks

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (03378)

Founded in 2014, Hansi Aitai Biomedical Technology (Wuhan) Co., Ltd. is an innovative biotechnology company focusing on structural biology, translational medicine and clinical development. The company is committed to developing a new generation of immunotherapies to provide affordable, safe and efficient medical solutions to patients around the world to meet major disease challenges. Adhering to an innovation-driven mis